INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARD (U54): (RFA-RM-09-004)

Components of Participating Organizations

This FOA is developed as a NIH Roadmap for Medical Research initiative. All NIH Institutes and Centers participate in Roadmap initiatives. This FOA will be administered by the National Center for Research Resources on behalf of the NIH. http://www.ncrr.nih.gov/.

Letters of Intent Receipt Date: September 14, 2009

Application Receipt Date: October 14, 2009

Earliest Anticipated Start Date: July 1, 2010

Expiration Date: October 15, 2009

The Clinical and Translational Science Award (CTSA) initiative assists institutions to create an integrated academic home for Clinical and Translational Science that has the resources to train and advance multi- and inter-disciplinary investigators and research teams with access to innovative research tools and information technologies that apply new knowledge and techniques to patient care. Clinical and Translational Science Awards (CTSAs) attract basic, translational, and clinical investigators, community clinicians, clinical practices, networks, professional societies, and industry to develop new professional interactions, programs, and research projects. Through innovative advanced degree programs, CTSAs foster the discipline of Clinical and Translational Science that is broader and deeper than their separate components.

This FOA will utilize the National Institutes of Health (NIH) cooperative agreement specialized center (U54) award mechanism. The total funds available for the new awards are approximately $20 million. Up to 4 awards are anticipated from this solicitation. The NIH intends to issue solicitations for additional CTSAs in future years. The NIH intends to issue solicitations for additional CTSAs in future years. Awards will vary in size due to the consolidation of multiple programs at the applicant institution(s) into the CTSA program proposal. Applicants may request support for up to five years. The annual total costs that may be requested will be limited in proportion to the combined current total costs of certain NIH awards (NCRR M01, NCRR-managed trans-NIH K30 and Roadmap T32 …